Familial hypercholesterolaemia: Cascade testing is tried and tested and cost effective.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.Current atherosclerosis reports · 2026
   Review
2. Implementing genomics and pharmacogenomics in the clinic: The National Human Genome Research Institute's genomic medicine portfolio.Atherosclerosis · 2016
   Review
3. Cascade genetic testing for mismatch repair gene mutations.Familial cancer · 2008
   Article
4. Familial hypercholesterolaemia: screening needs a fresh approach.BMJ (Clinical research ed.) · 2007
   Article

Corrections and comments

• Commented on by
  Familial hypercholesterolaemia: screening needs a fresh approach.2007
• Comment on
  Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.2007

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as